OFFICERS TRUE HEROES. MULTIPLE CONFIRMED CASES. AND I’M GOING TO LET THE DOCTOR HERE TAKE THIS WORD. BABESIOSIS IN MASSACHUSETTS, THAT’S A DISEASE PRIMARILY SPREAD BY DEER TICKS. SO WE TALK A LOT ...
Signing of a Patent License Agreement with Tufts Medical Center to jointly advance the development of tafenoquine for babesiosis treatment, indicating a strategic collaboration that enhances the ...
60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine, marketed as ...
Add Yahoo as a preferred source to see more of our stories on Google. https://www.tipranks.com/news/the-fly/wells-sees-potential-upside-after-glaukos-idose-repeat ...
WASHINGTON, D.C., April 08, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (SXTP) (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new ...
Breakthrough Therapy Designation request has been submitted to FDA Company to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA) ...
A newly published study in the Journal of Medical Entomology provides critical insights into the emergence of babesiosis in the Mid-Atlantic region, documenting human cases and the presence of Babesia ...
Canine babesiosis is a significant tick‐borne disease caused by protozoan parasites of the genus Babesia that invade and disrupt canine erythrocytes. The disease presents with a spectrum of clinical ...
WASHINGTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results